Last reviewed · How we verify

Carboplatin i.d. Days 1 & 15

Windy Hill Medical, Inc. · Phase 2 active Small molecule

Carboplatin i.d. Days 1 & 15 is a Platinum-based chemotherapy Small molecule drug developed by Windy Hill Medical, Inc.. It is currently in Phase 2 development for Advanced ovarian cancer, Small cell lung cancer, Non-small cell lung cancer. Also known as: Paraplatin.

Carboplatin is a platinum-based chemotherapy drug that works by crosslinking DNA, thereby inhibiting cancer cell replication.

Carboplatin is a platinum-based chemotherapy drug that works by crosslinking DNA, thereby inhibiting cancer cell replication. Used for Advanced ovarian cancer, Small cell lung cancer, Non-small cell lung cancer.

At a glance

Generic nameCarboplatin i.d. Days 1 & 15
Also known asParaplatin
SponsorWindy Hill Medical, Inc.
Drug classPlatinum-based chemotherapy
TargetDNA
ModalitySmall molecule
Therapeutic areaOncology
PhasePhase 2

Mechanism of action

Carboplatin is a second-generation platinum-based chemotherapy drug that works by forming platinum-DNA adducts, which interfere with DNA replication and transcription, ultimately leading to cell death. This mechanism is thought to be responsible for its antitumor activity.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Carboplatin i.d. Days 1 & 15

What is Carboplatin i.d. Days 1 & 15?

Carboplatin i.d. Days 1 & 15 is a Platinum-based chemotherapy drug developed by Windy Hill Medical, Inc., indicated for Advanced ovarian cancer, Small cell lung cancer, Non-small cell lung cancer.

How does Carboplatin i.d. Days 1 & 15 work?

Carboplatin is a platinum-based chemotherapy drug that works by crosslinking DNA, thereby inhibiting cancer cell replication.

What is Carboplatin i.d. Days 1 & 15 used for?

Carboplatin i.d. Days 1 & 15 is indicated for Advanced ovarian cancer, Small cell lung cancer, Non-small cell lung cancer, Bladder cancer, Testicular cancer.

Who makes Carboplatin i.d. Days 1 & 15?

Carboplatin i.d. Days 1 & 15 is developed by Windy Hill Medical, Inc. (see full Windy Hill Medical, Inc. pipeline at /company/windy-hill-medical-inc).

Is Carboplatin i.d. Days 1 & 15 also known as anything else?

Carboplatin i.d. Days 1 & 15 is also known as Paraplatin.

What drug class is Carboplatin i.d. Days 1 & 15 in?

Carboplatin i.d. Days 1 & 15 belongs to the Platinum-based chemotherapy class. See all Platinum-based chemotherapy drugs at /class/platinum-based-chemotherapy.

What development phase is Carboplatin i.d. Days 1 & 15 in?

Carboplatin i.d. Days 1 & 15 is in Phase 2.

What are the side effects of Carboplatin i.d. Days 1 & 15?

Common side effects of Carboplatin i.d. Days 1 & 15 include Myelosuppression, Nausea and vomiting, Neutropenia, Thrombocytopenia, Anemia.

What does Carboplatin i.d. Days 1 & 15 target?

Carboplatin i.d. Days 1 & 15 targets DNA and is a Platinum-based chemotherapy.

Related